Open access
Oct 2026
A Metabolic Cluster–Derived Risk Model for Prognostic Stratification, Immunometabolic Profiling, and Therapeutic Sensitivity Prediction in Prostate Cancer
Purpose Metabolic reprogramming is a hallmark of prostate cancer; however, the clinical utility of metabolism-related genes for prognostic stratification remains limited. Patients and Methods Prostate cancer patients from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were stratified into me...
Wen-Si Liu, Cong Wang, Tao Su et al.
· Cancer Management and Resear... · 0 citations